Niagen Bioscience (NAGE) Receivables - Net (2016 - 2025)
Niagen Bioscience (NAGE) has disclosed Receivables - Net for 15 consecutive years, with $9.7 million as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 25.4% to $9.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.7 million through Dec 2025, up 25.4% year-over-year, with the annual reading at $9.7 million for FY2025, 25.4% up from the prior year.
- Receivables - Net for Q4 2025 was $9.7 million at Niagen Bioscience, up from $8.5 million in the prior quarter.
- The five-year high for Receivables - Net was $9.7 million in Q4 2025, with the low at $2.8 million in Q2 2023.
- Average Receivables - Net over 5 years is $6.4 million, with a median of $6.6 million recorded in 2024.
- The sharpest move saw Receivables - Net crashed 66.99% in 2023, then soared 179.21% in 2024.
- Over 5 years, Receivables - Net stood at $5.2 million in 2021, then surged by 62.3% to $8.5 million in 2022, then plummeted by 66.99% to $2.8 million in 2023, then surged by 177.43% to $7.8 million in 2024, then grew by 25.4% to $9.7 million in 2025.
- According to Business Quant data, Receivables - Net over the past three periods came in at $9.7 million, $8.5 million, and $9.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.